ZOLL Medical: ECG Cable Origin and the Fraud Claims Left Open

ZOLL Medical agreed to pay $400,000 to resolve ECG cable origin allegations involving Chinese-made replacement cables offered to federal buyers as American-made. The country-of-origin case began with a former employee who brought the government information about the sales. For someone inside a medical-device business, the connection is concrete: where the replacement part was made, what the company told the buyer, and which government orders followed.

The resolution announced on May 17, 2023 took an unusual form. The United States settled claims over mistaken payments and broken contract promises while expressly keeping its fraud claims open.

The Cable and the Government Purchase

The ZOLL Medical ECG cable origin allegations concerned replacement electrocardiogram cables used with defibrillators and cardiac monitors. ZOLL Medical Corporation, headquartered in Chelmsford, Massachusetts, supplies medical devices and technology and contracts with the federal government to provide those machines.

According to the settlement agreement’s account of the allegations, ZOLL represented to government officials in January 2019 that the replacement cables were manufactured in the United States. The government alleged that they were made in China and that ZOLL sold them to federal purchasers through November 2022 despite knowing, or having reason to know, that the cables failed the applicable origin requirements.

The government tied those representations to claims for payment. It alleged that ZOLL received money it was not entitled to receive because the cables failed the Trade Agreements Act requirements governing the purchases. The Justice Department explained that the applicable rule permitted American-made goods or goods from designated countries, and China was not a designated country.

The agreement names the Department of Veterans Affairs and the Department of Health and Human Services alongside the Department of Defense. The U.S. Attorney’s Office for the District of Rhode Island announced the resolution, and the Department of Veterans Affairs Office of Inspector General, Criminal Investigations Division, Northeast Field Office, and the Department of Health and Human Services Office of Inspector General, Boston Field Office, were among the investigators.

The replacement cable carried its own origin claim. Someone who knew its supplier could know a part of the purchasing story that the government buyer never saw.

An Alternate Remedy Reserving FCA Claims

An alternate remedy reserving FCA claims was the structure of ZOLL’s settlement: the government resolved claims for money paid by mistake and for broken contract promises while keeping its False Claims Act and other fraud claims open.

The former employee had brought a qui tam case alleging violations of the False Claims Act. After investigating those allegations, the government chose the payment and contract route for this agreement. It sought money back for payments it said should not have been made and promises it said ZOLL had broken.

The payment settled those specified claims. The government expressly reserved its fraud claims over the same cable sales.

How Much Money Can a Whistleblower Get From a Qui Tam Lawsuit?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. ZOLL’s agreement provided a whistleblower share of the recovery, payable after the government received the settlement money.

ZOLL separately agreed to pay $35,000 for expenses, whistleblower attorneys’ fees and costs. That payment had its own terms, apart from the former employee’s reward.

Why the Factory Matters More Than the Mailing Address

Origin requirements concern the product’s manufacturing history. A company’s U.S. headquarters and a product’s U.S. manufacturing origin answer different questions. In ZOLL’s case, the government alleged that an American medical-device supplier offered replacement cables made in China under a representation that they were American-made.

The Buy American rules and trade-agreement purchasing rules use different tests. Buy American can examine domestic manufacture and component costs. Under the Trade Agreements purchasing clause, designated-country origin can turn on substantial transformation: manufacturing that creates a new article with a different name, character or use.

That is why we start with the origin promise in the particular contract and compare it with what happened at the factory. A distributor’s address cannot supply that manufacturing history. Supplier documentation, production records and shipping records describe different parts of it.

For a replacement component, we keep the inquiry attached to that component. The government identified the cables offered for use with the monitors and defibrillators. The useful connection runs from the cable’s source to the representation made about that cable and then to the order and payment.

The Pattern in Medical Procurement

Other medical-supply cases show origin claims appearing in certificates, packaging and product lists. Each gives a different employee a view of the discrepancy between the goods and the government’s purchasing information.

In the Justice Department’s 2015 Medtronic settlement, the company agreed to pay $4.41 million to resolve origin allegations covering VA and Defense purchases. The government alleged that products certified as originating in the United States or designated countries came from China and Malaysia. The products included cardiac-lead anchoring sleeves, spinal instruments and a handheld patient assistant. Like ZOLL’s replacement cables, accessories formed part of the origin dispute.

The allegations against ICP Medical reached the warehouse. The government alleged that Chinese-origin designations were removed from packaging for body bags, gowns and scrubs, that the goods were reboxed, and that some packages received U.S. flag stickers. VA facilities were among the customers. We see the absurdity in that alleged substitution: changing the box could change what the buyer saw, while leaving where the goods were made untouched.

Coloplast’s self-disclosure concerned a manufacturing change that the contract information failed to follow. The company disclosed that it had misapplied the substantial-transformation standard, reported incorrect countries of origin and left products on its VA contract after production moved to non-designated countries. That case also covered pricing allegations. The origin lesson is specific: the factory moved, while the products remained available under the contract.

The certificate, the original box and the notice that production moved can each expose a different part of the same purchasing problem. Someone working in sourcing, packaging or contract administration may understand the discrepancy before anyone investigating the payment does.

What Proof Do You Need as a Whistleblower?

For an origin case like ZOLL’s, we connect the manufacturer’s records, the company’s representation and the government transaction. The billing evidence gives the product discrepancy its connection to public money.

Supplier and production records can explain where the replacement cable was made. Packaging and label history can show how the product was presented. Shipping records connect the goods moving through the supply chain, while government orders, invoices and payments connect them to the purchase. We examine those records together with the origin promise in the contract.

The government’s ZOLL allegations also addressed what the company knew when it sold the cables. That makes the relationship between sourcing information and sales representations central to our assessment. We work with insiders to understand which decisions they saw and how those decisions reached the government buyer.

The Settlement Costs Could Not Go Back to Taxpayers

ZOLL’s agreement required it to bear the settlement-related costs without charging them to federal contracts. The restriction reached beyond the settlement payment to investigation, defense, corrective action, negotiating and carrying out the agreement, and payments connected to the whistleblower’s case.

The agreement required ZOLL to account for those costs separately and prohibited charging them directly or indirectly to United States contracts.

The requirement also looked backward. ZOLL had to identify and repay any such costs previously included in requests for government payment. The United States retained the right to audit the books and challenge ZOLL’s calculations.

For an accounting insider, that creates a concrete comparison between the costs the agreement excludes and the costs submitted for reimbursement. It connects this origin settlement to government contractor cost mischarging: which expenses reached the government, through which accounts, and whether the required corrections followed.

You Know the Source Behind the Sale

If you know where a replacement component was made or how its origin reached a federal buyer, talk with our whistleblower experts about the sales you saw. We build your strongest government procurement whistleblower case around your knowledge, bring in government procurement fraud whistleblower lawyers who understand medical-device sourcing, and stay beside you throughout the case.